Multimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and Intervention

NCT07282184 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

144

Enrollment

OTHER

Sponsor class

Conditions

Hepotacellular Carcinoma

Interventions

COMBINATION_PRODUCT: Neoadjuvant HAIC + Lenvatinib + PD-1 Inhibitor
PROCEDURE: Curative Liver Resection
OTHER: Multimodal AI Risk Stratification

Sponsor

Tongji Hospital